Gema Moreno-Bueno

17PUBLICATIONS
61CO-AUTHORS
Molecular targetsPredictive and prognostic markersTissue engineeringCancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 03, 2026
Disruption of MCL1/BOK transmembrane interaction as a novel strategy to induce cell death in tumours.

|Apr 28, 2026
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panel.

|Mar 04, 2026
A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential.

Raúl Jiménez-Castaño, Nitin Narwade, Gema Moreno-Bueno

|Oct 16, 2024
Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations.

Khalil Kass Youssef, Nitin Narwade, Aida Arcas

|Feb 15, 2024
TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling.

Carlos Marugán, Natalia Sanz-Gómez, Beatriz Ortigosa

|Jan 23, 2024
HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells.

Jesús Morillo-Bernal, Patricia Pizarro-García, Gema Moreno-Bueno

Pageof 3

Frequent Collaborators

3 joint publications

Carlos Casas-Arozamena

3 joint publications

Antonio Gil-Moreno

3 joint publications

Miguel Abal

2 joint publications

Laura Muinelo-Romay